Bruce Keyt
Company: IGM Biosciences
Job title: Chief Scientific Officer
Seminars:
Panel: The Past, Present & Future of Complement in Oncology 9:30 am
Where to target for oncology indications? Discussing complement dependent mechanisms in angiogenesis How can newly discovered complement functions be targeted for therapy?Read more
day: Conference Day Two